Advertisement
Ibrutinib
Specialty Drug

Imbruvica

IBRUTINIB is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat mantle cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, marginal zone lymphoma, and Waldenstrom macroglobulinemia. Compare kinase inhibitors.

Ibrutinib Latest News

Get the latest updates on this drug from the GoodRx medical team

Is Your Medication on the FDA Watch List?

The GoodRx Pharmacist - April 18, 2017

If you have ever experienced a serious reaction to a medication, you are not alone. In 2000, the Institute of Medicine reported that more than 2 million serious adverse drug reactions occur each year. The FDA keeps track of these serious events through a reporting system and releases them quarterly. This system, the FDA Adverse Event Reporting System (FAERS), is a database that contains information on adverse events and medication error reports that have been submitted. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.